Value, Access, and Regulatory Strategy Conference
pharmafile | September 4, 2018 | News story | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Conference, London, Regulatory Strategy, access, dia
Tuesday, October 09, 2018 – Wednesday, October 10, 2018
Renaissance London Heathrow Hotel, UK
See Map
Learn more about the event here
Register for the event here
Event Type: Conference
Europe is facing challenging discussions related to affordability and patient access. Ongoing collaboration activities between national HTAs and between HTAs and Regulators hold some promise for better alignment of requirements that will allow more predictable assessment outcomes in Europe. Stakeholders have started to dialogue across disciplines and legislators are proposing new instruments to set up a sustainable system for EU collaboration on clinical value assessments.
“DIA’s Value, Access, and Regulatory Strategy Conference provides the only forum for open, interactive dialogue between policy makers, payers, HTA bodies, and other stakeholders, for discussing short-term strategies and long-term market solutions.” Solange Corriol-Rohou, DrMed, Md, PhD, Senior Director, Speaker at the event, Global Regulatory Affairs & Policy, Europe, AstraZeneca, Global Medicines Development, France
Related Content
Touchlight completes expansion of one of world’s largest DNA manufacturing facilities in London
Touchlight, a company that focuses on pioneering enzymatic DNA production, has announced that it has …
FlyPharma Europe, Vienna: the early bird deal for FlyPharma Vienna closes on 24 May
Act now! The early bird deal for FlyPharma Vienna closes on 24 May. Contact Angela …
MSD unveils plans for $1.3bn central London research centre
MSD has lifted the lid on plans to build a $1.3 billion research centre in …